
Ep. 372 - Biotech IPOs, Biosecure Act, cachexia pipeline
Jun 15, 2026 - 25:13
Radio and PodcastLive Radio & Podcasts
A flurry of deals, several with sizable upfront payments, has energized the biotech sector in March. On the latest BioCentury This Week podcast, BioCentury’s Paul Bonanos assesses last week’s deals by Merck, which is lay...
Ep. 357 - Deal-O-rama, Gilead and Tallon's U.K. vision is an episode from BioCentury This Week by BioCentury. A flurry of deals, several with sizable upfront payments, has energized the biotech sector in March. On the latest BioCentury This...
This episode belongs to BioCentury This Week.
Use the player on this page to stream the episode online.
Published Mar 30, 2026, 28:38 long, audio available.